You can participate in this study if: you were assigned female at birth you are 18-55 years of age you have been diagnosed with, or are suspected to have, endometriosis you are currently taking or have taken Glucagon-Like Peptide-1 (GLP-1) medications in the past
Statements Author contributions ZX: Conceptualization, Data curation, Formal Analysis, Writing original draft, Writing review and editing
Outcomes were measured using PROMIS T-scoresvalidated, widely used patient-reported outcome instruments: Pain Intensity: 65.0 58.7 ( 6.3, p 98 percent purity via HPLC/MS, third-party testing for heavy metals and microbial contamination, and documentation of raw material endotoxin levels
Minimal providers can help adjust your semaglutide plan, whether youre just starting out, moving between dose stages, or unsure if your current dose still matches your goals
Oral forms work more slowly